Follow the people · Insider
Victoria L. Creamer
Victoria L. Creamer files insider transactions with the SEC as an evp & chief people officer of Charles River Laboratories International. We hold 1 disclosed purchase or sale filed since 27 February 2015, 1 of them in the last 90 days.
- Files for 2 companiesCRL, ITT
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 February 2021 — 6 August 2026EVP & Chief People Officer · Charles River Laboratories International 67 Form 4 lines · source: SEC Form 4
- Filed 25 February 2015 — 21 May 2018Officer · Itt 11 Form 4 lines · source: SEC Form 4
Every transaction
78 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 6 Aug 2026 | 10 Aug 2026SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories International | 4,179 shares | up +4.8% | up +0.5% |
| 6 Aug 2026 | 10 Aug 2026SEC Form 4 | 4 d | sold on the open market | Charles River Laboratories International | 4,179 shares | up +4.8% | up +0.5% |
| 6 Aug 2026 | 10 Aug 2026SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 4,179 shares | up +4.8% | up +0.5% |
| 31 May 2026 | 2 Jun 2026SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 194 shares | up +54.0% | up +59.2% |
| 30 May 2026 | 2 Jun 2026SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 616 shares | up +54.0% | up +59.2% |
| 29 May 2026 | 2 Jun 2026SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 5,135 shares | up +54.0% | up +59.2% |
| 27 May 2026 | 28 May 2026SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 148 shares | up +69.2% | up +53.5% |
| 26 May 2026 | 28 May 2026SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 198 shares | up +77.6% | up +53.5% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 5,006 shares | up +32.2% | up +38.2% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 1,296 shares | up +32.2% | up +38.2% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 5,006 shares | up +32.2% | up +38.2% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 1,296 shares | up +32.2% | up +38.2% |
| 31 May 2025 | 3 Jun 2025SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 120 shares | up +105.2% | up +101.0% |
| 30 May 2025 | 3 Jun 2025SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 6,252 shares | up +105.2% | up +101.0% |
| 28 May 2025 | 29 May 2025SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 62 shares | up +104.3% | up +102.1% |
| 27 May 2025 | 29 May 2025SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 91 shares | up +100.8% | up +102.1% |
| 26 May 2025 | 29 May 2025SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 123 shares | up +103.6% | up +102.1% |
| 31 Jan 2025 | 3 Feb 2025SEC Form 4 | 3 d | was grantednot a trade | Charles River Laboratories International | 2,468 shares | up +68.9% | up +72.2% |
| 31 Jan 2025 | 3 Feb 2025SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 791 shares | up +68.9% | up +72.2% |
| 31 May 2024 | 4 Jun 2024SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories Internationalderivative | 4,470 shares | up +33.5% | up +32.4% |
| 31 May 2024 | 4 Jun 2024SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 1,967 shares | up +33.5% | up +32.4% |
| 29 May 2024 | 29 May 2024SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 190 shares | up +31.6% | up +31.6% |
| 28 May 2024 | 30 May 2024SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 114 shares | up +29.8% | up +32.7% |
| 28 May 2024 | 29 May 2024SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 77 shares | up +29.8% | up +31.6% |
| 27 May 2024 | 30 May 2024SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 170 shares | up +28.1% | up +32.7% |
| 27 May 2024 | 29 May 2024SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 122 shares | up +28.1% | up +31.6% |
| 26 May 2024 | 30 May 2024SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 180 shares | up +28.1% | up +32.7% |
| 26 May 2024 | 29 May 2024SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 180 shares | up +28.1% | up +31.6% |
| 29 Feb 2024 | 1 Mar 2024SEC Form 4 | 1 d | sold on the open market | Charles River Laboratories International | 5,000 shares | up +9.5% | up +5.3% |
| 29 Jan 2024 | 25 Mar 2024SEC Form 4 | 56 d | was grantednot a trade | Charles River Laboratories International | 2,934 shares | up +24.0% | up +4.8% |
| 29 Jan 2024 | 25 Mar 2024SEC Form 4 | 56 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 924 shares | up +24.0% | up +4.8% |
| 29 Jan 2024 | 31 Jan 2024SEC Form 4 | 2 d | was grantednot a trade | Charles River Laboratories International | 2,997 shares | up +24.0% | up +28.7% |
| 29 Jan 2024 | 31 Jan 2024SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 953 shares | up +24.0% | up +28.7% |
| 14 Dec 2023 | 18 Dec 2023SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 3,381 shares | up +21.4% | up +22.0% |
| 14 Dec 2023 | 18 Dec 2023SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 2,145 shares | up +21.4% | up +22.0% |
| 14 Dec 2023 | 18 Dec 2023SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories International | 3,381 shares | up +21.4% | up +22.0% |
| 14 Dec 2023 | 18 Dec 2023SEC Form 4 | 4 d | exercised options overnot a trade | Charles River Laboratories International | 2,145 shares | up +21.4% | up +22.0% |
| 14 Dec 2023 | 18 Dec 2023SEC Form 4 | 4 d | sold on the open market | Charles River Laboratories International | 5,526 shares | up +21.4% | up +22.0% |
| 29 May 2023 | 31 May 2023SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 190 shares | up +43.4% | up +43.9% |
| 28 May 2023 | 31 May 2023SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 115 shares | up +43.4% | up +43.9% |
| 27 May 2023 | 31 May 2023SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 170 shares | up +43.4% | up +43.9% |
| 26 May 2023 | 31 May 2023SEC Form 4 | 5 d | was grantednot a trade | Charles River Laboratories Internationalderivative | 4,820 shares | up +43.4% | up +43.9% |
| 26 May 2023 | 31 May 2023SEC Form 4 | 5 d | was grantednot a trade | Charles River Laboratories International | 2,009 shares | up +43.4% | up +43.9% |
| 22 Feb 2023 | 22 Feb 2023SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 181 shares | up +27.0% | up +27.0% |
| 1 Feb 2023 | 22 Feb 2023SEC Form 4 | 21 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 343 shares | up +12.1% | up +27.0% |
| 31 Jan 2023 | 30 Jan 2023SEC Form 4 | -1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 2,692 shares | up +14.4% | up +16.1% |
| 27 Jan 2023 | 30 Jan 2023SEC Form 4 | 3 d | was grantednot a trade | Charles River Laboratories International | 7,229 shares | up +13.6% | up +16.1% |
| 29 May 2022 | 31 May 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 190 shares | up +13.9% | up +18.9% |
| 28 May 2022 | 31 May 2022SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 114 shares | up +13.9% | up +18.9% |
| 27 May 2022 | 31 May 2022SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories Internationalderivative | 4,036 shares | up +13.9% | up +18.9% |
| 27 May 2022 | 31 May 2022SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 1,493 shares | up +13.9% | up +18.9% |
| 22 Feb 2022 | 23 Feb 2022SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 180 shares | down −3.9% | down −1.8% |
| 1 Feb 2022 | 1 Feb 2022SEC Form 4 | 0 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 343 shares | down −17.0% | down −17.0% |
| 28 Jan 2022 | 1 Feb 2022SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 6,302 shares | down −13.5% | down −17.0% |
| 28 Jan 2022 | 1 Feb 2022SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 2,395 shares | down −13.5% | down −17.0% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 2,145 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 3,380 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories Internationalderivative | 1,392 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories International | 2,145 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories International | 3,380 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Charles River Laboratories International | 1,392 shares | down −33.1% | down −33.3% |
| 16 Aug 2021 | 17 Aug 2021SEC Form 4 | 1 d | sold on the open market | Charles River Laboratories International | 6,917 shares | down −33.1% | down −33.3% |
| 29 May 2021 | 1 Jun 2021SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 127 shares | down −17.6% | down −16.4% |
| 28 May 2021 | 1 Jun 2021SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories International | 1,006 shares | down −17.6% | down −16.4% |
| 28 May 2021 | 1 Jun 2021SEC Form 4 | 4 d | was grantednot a trade | Charles River Laboratories Internationalderivative | 3,110 shares | down −17.6% | down −16.4% |
| 22 Feb 2021 | 24 Feb 2021SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 121 shares | down −1.8% | down −3.4% |
| 1 Feb 2021 | 2 Feb 2021SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Charles River Laboratories International | 251 shares | up +4.6% | up +2.2% |
| 21 May 2018 | 22 May 2018SEC Form 4 | 1 d | exercised options overnot a trade | Ittderivative | 7,640 shares | up +259.2% | up +265.6% |
| 21 May 2018 | 22 May 2018SEC Form 4 | 1 d | exercised options overnot a trade | Itt | 7,640 shares | up +259.2% | up +265.6% |
| 21 May 2018 | 22 May 2018SEC Form 4 | 1 d | sold on the open market | Itt | 7,640 shares | up +259.2% | up +265.6% |
| 27 Feb 2018 | 28 Feb 2018SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Itt | 3,237 shares | up +279.7% | up +295.1% |
| 26 Feb 2018 | 28 Feb 2018SEC Form 4 | 2 d | was grantednot a trade | Itt | 3,615 shares | up +272.2% | up +295.1% |
| 26 Feb 2018 | 28 Feb 2018SEC Form 4 | 2 d | was grantednot a trade | Itt | 3,143 shares | up +272.2% | up +295.1% |
| 23 Feb 2017 | 24 Feb 2017SEC Form 4 | 1 d | was grantednot a trade | Itt | 4,500 shares | up +375.7% | up +372.7% |
| 19 Feb 2016 | 23 Feb 2016SEC Form 4 | 4 d | was grantednot a trade | Itt | 2,765 shares | up +500.6% | up +496.3% |
| 19 Feb 2016 | 23 Feb 2016SEC Form 4 | 4 d | was grantednot a trade | Ittderivative | 10,050 shares | up +500.6% | up +496.3% |
| 25 Feb 2015 | 27 Feb 2015SEC Form 4 | 2 d | was grantednot a trade | Itt | 4,610 shares | up +377.5% | up +382.7% |
| 25 Feb 2015 | 27 Feb 2015SEC Form 4 | 2 d | was grantednot a trade | Ittderivative | 7,640 shares | up +377.5% | up +382.7% |
Both percentages are the stock’s move, not Victoria L. Creamer’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 78 of the 78 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.